Ryushi Tazawa Selected Research

Pulmonary Alveolar Proteinosis

1/2021	Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis.
1/2020	Inhaled GM-CSF for Pulmonary Alveolar Proteinosis. Reply.
1/2020	Validation of a new serum granulocyte-macrophage colony-stimulating factor autoantibody testing kit.
1/2019	Inhaled GM-CSF for Pulmonary Alveolar Proteinosis.
1/2019	Memory B cell pool of autoimmune pulmonary alveolar proteinosis patients contains higher frequency of GM-CSF autoreactive B cells than healthy subjects.
1/2018	Assay system development to measure the concentration of sargramostim with high specificity in patients with autoimmune pulmonary alveolar proteinosis after single-dose inhalation.
1/2018	Peripheral alveolar nitric oxide concentration reflects alveolar inflammation in autoimmune pulmonary alveolar proteinosis.
8/2017	Sequential Granulocyte-Macrophage Colony-Stimulating Factor Inhalation after Whole-Lung Lavage for Pulmonary Alveolar Proteinosis. A Report of Five Intractable Cases.
1/2017	Elderly-onset hereditary pulmonary alveolar proteinosis and its cytokine profile.
8/2015	Outcome of corticosteroid administration in autoimmune pulmonary alveolar proteinosis: a retrospective cohort study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ryushi Tazawa Research Topics

Disease

24	Pulmonary Alveolar Proteinosis 01/2021 - 05/2005
6	Fabry Disease (Fabry's Disease) 06/2021 - 04/2013
6	Neoplasms (Cancer) 02/2012 - 01/2002
3	Lung Diseases (Lung Disease) 01/2021 - 01/2017
2	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 10/2017 - 11/2016
2	Infections 08/2015 - 07/2004
2	Acquired Pulmonary Alveolar Proteinosis 11/2009 - 04/2008
2	Lung Neoplasms (Lung Cancer) 07/2004 - 02/2002
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021
1	Inflammation (Inflammations) 01/2018
1	Stomatitis 10/2017
1	Rare Diseases (Rare Disease) 08/2017
1	Pneumonia (Pneumonitis) 11/2016
1	Disease Progression 11/2016
1	Hypoxia (Hypoxemia) 04/2008
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2004
1	Respiratory Sounds (Crackle) 04/2003
1	Hypoparathyroidism 04/2003
1	Lewis Lung Carcinoma 07/2002
1	Neoplasm Metastasis (Metastasis) 02/2002
1	Adenocarcinoma 01/2002

Drug/Important Bio-Agent (IBA)

20	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020 - 05/2005
11	AutoantibodiesIBA 01/2019 - 05/2005
10	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2021 - 02/2012
8	Biomarkers (Surrogate Marker)IBA 06/2021 - 01/2006
5	Surface-Active Agents (Surfactants)IBA 01/2021 - 01/2015
5	globotriaosyl lysosphingolipidIBA 08/2019 - 04/2013
5	Proteins (Proteins, Gene)FDA Link 08/2017 - 02/2002
3	GalactosidasesIBA 06/2021 - 04/2013
3	Immunoglobulin G (IgG)IBA 01/2019 - 08/2010
3	CytokinesIBA 01/2017 - 07/2002
2	sargramostim (Leukine)FDA Link 01/2019 - 01/2018
2	Pharmaceutical PreparationsIBA 10/2017 - 11/2016
2	Sirolimus (Rapamycin)FDA Link 10/2017 - 11/2016
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 07/2002 - 02/2002
2	Angiogenesis InhibitorsIBA 07/2002 - 02/2002
1	Mitochondrial Uncoupling ProteinsIBA 01/2022
1	Smad7 ProteinIBA 01/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022
1	Oxygen (Dioxygen)IBA 01/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018
1	lipoarabinomannan (LAM)IBA 11/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2015
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 12/2013
1	EnzymesIBA 04/2013
1	Immunoglobulin M (IgM)IBA 05/2012
1	Interleukin-17 (Interleukin 17)IBA 02/2012
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2012
1	Granulocyte-Macrophage Colony-Stimulating Factor Receptors (GM-CSF Receptor)IBA 08/2010
1	Carbon MonoxideIBA 04/2008
1	Pulmonary Surfactants (Pulmonary Surfactant)IBA 04/2008
1	VaccinesIBA 01/2005
1	Interleukin-12 (IL 12)IBA 01/2005
1	InterleukinsIBA 01/2005
1	Interleukin-4 (Interleukin 4)IBA 01/2005
1	Secretory Leukocyte Peptidase InhibitorIBA 07/2004
1	SteroidsIBA 04/2003
1	Vitamin D FDA LinkGeneric 04/2003
1	Interleukin-1beta (Interleukin 1 beta)IBA 07/2002
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 07/2002
1	O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA 07/2002
1	Messenger RNA (mRNA)IBA 07/2002
1	Peptides (Polypeptides)IBA 02/2002
1	matrigelIBA 02/2002
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2002
1	Arachidonic Acid (Vitamin F)IBA 01/2002
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2002
1	Complementary DNA (cDNA)IBA 01/2002
1	Prostaglandins EIBA 01/2002
1	Prostaglandins DIBA 01/2002
1	ProstaglandinsIBA 01/2002
1	ThromboxanesIBA 01/2002

Therapy/Procedure

7	Therapeutics 11/2016 - 02/2002
3	Respiratory Therapy (Therapy, Respiratory) 01/2020 - 01/2006
1	Subcutaneous Injections 04/2014
1	Immunotherapy 01/2005
1	Intraperitoneal Injections 02/2002